The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
The closing price of Akero Therapeutics Inc (NASDAQ: AKRO) was $47.47 for the day, down -4.29% from the previous closing price of $49.60. In other words, the price has decreased by -$4.29 from its previous closing price. On the day, 0.84 million shares were traded.
Ratios:
Our analysis of AKRO’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 17.25 and its Current Ratio is at 17.25. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.05.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, BofA Securities on January 30, 2025, Upgraded its rating to Buy and sets its target price to $63 from $35 previously.
On January 27, 2025, H.C. Wainwright reiterated its Buy rating and also lowered its target price recommendation from $50 to $72.
On November 18, 2024, Citigroup started tracking the stock assigning a Buy rating and target price of $65.Citigroup initiated its Buy rating on November 18, 2024, with a $65 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Feb 18 ’25 when Yale Catriona sold 10,000 shares for $49.87 per share. The transaction valued at 498,660 led to the insider holds 95,648 shares of the business.
Cheng Andrew sold 30,000 shares of AKRO for $1,581,994 on Feb 10 ’25. The President and CEO now owns 686,062 shares after completing the transaction at $52.73 per share. On Jan 30 ’25, another insider, Graham G. Walmsley, who serves as the Director of the company, bought 200,000 shares for $48.00 each. As a result, the insider paid 9,600,000 and bolstered with 1,000,000 shares of the company.
Stock Price History:
Over the past 52 weeks, AKRO has reached a high of $58.40, while it has fallen to a 52-week low of $17.86. The 50-Day Moving Average of the stock is 26.36%, while the 200-Day Moving Average is calculated to be 62.34%.
Shares Statistics:
A total of 69.61M shares are outstanding, with a floating share count of 66.61M. Insiders hold about 11.34% of the company’s shares, while institutions hold 92.33% stake in the company.
